Corporate & Investor Presentation
Digital health solutions for inhaled COPD pharmaceuticals
•
ResMed has end-to-end digital health solutions for COPD
patients across stages I, II, III, IV of the disease
Uses sensors with inhalers to track medication usage and
provide personal feedback and insights
UPSTREAM
Establishes ResMed as a leading provider of COPD and
asthma patient management solutions
Enables digital integration of care through the progression
of the disease
gsk
Customers include:
Boehringer
Ingelheim
ORION
NOVARTIS
$$
Patients + $$
Increased drug
adherence and sales
Pharma companies signed
represent 90% of long-acting
respiratory inhalation drugs
Improved clinical trial
speed and enhanced time
to market
49 2021 ResMed | Corporate & Investor Presentation - updated 29APR21
DOWNSTREAM
Health and economic
outcomes
Payers
Anthem
PBMs
EXPRESS SCRIPTS
Propeller
Clinical insights and
efficiencies
Health
systems
Dignity Health.
($$
Patients + $$
Pharmacies
Walgreens
Patient Acquisition
ResMedView entire presentation